CN110201150A - A kind of drug increasing the anti-HPV of human body cell activity - Google Patents
A kind of drug increasing the anti-HPV of human body cell activity Download PDFInfo
- Publication number
- CN110201150A CN110201150A CN201910630800.4A CN201910630800A CN110201150A CN 110201150 A CN110201150 A CN 110201150A CN 201910630800 A CN201910630800 A CN 201910630800A CN 110201150 A CN110201150 A CN 110201150A
- Authority
- CN
- China
- Prior art keywords
- human body
- hpv
- dosage
- cell activity
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000694 effects Effects 0.000 title claims abstract description 25
- 229940079593 drug Drugs 0.000 title claims abstract description 14
- 239000003814 drug Substances 0.000 title claims abstract description 14
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 36
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 36
- 235000008434 ginseng Nutrition 0.000 claims abstract description 36
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 20
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 20
- 235000014676 Phragmites communis Nutrition 0.000 claims abstract description 20
- 240000008397 Ganoderma lucidum Species 0.000 claims abstract description 19
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims abstract description 19
- 108010010803 Gelatin Proteins 0.000 claims abstract description 18
- 241001248610 Ophiocordyceps sinensis Species 0.000 claims abstract description 18
- 229920000159 gelatin Polymers 0.000 claims abstract description 18
- 239000008273 gelatin Substances 0.000 claims abstract description 18
- 235000019322 gelatine Nutrition 0.000 claims abstract description 18
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 18
- 239000007788 liquid Substances 0.000 claims abstract description 17
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 claims abstract description 15
- 244000291414 Vaccinium oxycoccus Species 0.000 claims abstract description 15
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 claims abstract description 15
- 235000004634 cranberry Nutrition 0.000 claims abstract description 15
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 15
- 239000011707 mineral Substances 0.000 claims abstract description 15
- 241001265053 Dolichandra unguis-cati Species 0.000 claims abstract description 14
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 claims abstract description 11
- 241000208680 Hamamelis mollis Species 0.000 claims abstract description 11
- 241000212322 Levisticum officinale Species 0.000 claims abstract description 11
- 239000001645 levisticum officinale Substances 0.000 claims abstract description 11
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 claims abstract description 11
- 229940052490 naringin Drugs 0.000 claims abstract description 11
- 229930019673 naringin Natural products 0.000 claims abstract description 11
- 229940118846 witch hazel Drugs 0.000 claims abstract description 11
- 241001116389 Aloe Species 0.000 claims abstract description 10
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 10
- 244000081757 Phalaris arundinacea Species 0.000 claims abstract description 9
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 6
- 240000001432 Calendula officinalis Species 0.000 claims abstract description 6
- 235000005881 Calendula officinalis Nutrition 0.000 claims abstract description 6
- 244000143590 Salvia chinensis Species 0.000 claims abstract description 6
- 235000007154 Salvia chinensis Nutrition 0.000 claims abstract description 6
- 235000005794 Salvia japonica Nutrition 0.000 claims abstract description 6
- 241000208340 Araliaceae Species 0.000 claims abstract 7
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 22
- 229920002674 hyaluronan Polymers 0.000 claims description 18
- 229960003160 hyaluronic acid Drugs 0.000 claims description 17
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 16
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims description 16
- 150000002515 isoflavone derivatives Chemical class 0.000 claims description 16
- 235000008696 isoflavones Nutrition 0.000 claims description 16
- 102000016942 Elastin Human genes 0.000 claims description 15
- 108010014258 Elastin Proteins 0.000 claims description 15
- 229920002549 elastin Polymers 0.000 claims description 15
- 239000011718 vitamin C Substances 0.000 claims description 11
- 240000000249 Morus alba Species 0.000 claims description 5
- 235000008708 Morus alba Nutrition 0.000 claims description 5
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 3
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 claims description 3
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 3
- 229910052804 chromium Inorganic materials 0.000 claims description 3
- 239000011651 chromium Substances 0.000 claims description 3
- 239000010941 cobalt Substances 0.000 claims description 3
- 229910017052 cobalt Inorganic materials 0.000 claims description 3
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 claims description 3
- 229910052802 copper Inorganic materials 0.000 claims description 3
- 239000010949 copper Substances 0.000 claims description 3
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 3
- 229910052711 selenium Inorganic materials 0.000 claims description 3
- 239000011669 selenium Substances 0.000 claims description 3
- 210000004881 tumor cell Anatomy 0.000 abstract description 20
- 210000004027 cell Anatomy 0.000 abstract description 19
- 239000000126 substance Substances 0.000 abstract description 14
- 208000022361 Human papillomavirus infectious disease Diseases 0.000 abstract description 11
- 229940011871 estrogen Drugs 0.000 abstract description 10
- 239000000262 estrogen Substances 0.000 abstract description 10
- 206010028980 Neoplasm Diseases 0.000 abstract description 9
- 208000009608 Papillomavirus Infections Diseases 0.000 abstract description 8
- 230000012010 growth Effects 0.000 abstract description 5
- 206010059313 Anogenital warts Diseases 0.000 abstract description 4
- 208000000907 Condylomata Acuminata Diseases 0.000 abstract description 4
- 208000019065 cervical carcinoma Diseases 0.000 abstract description 4
- 210000004392 genitalia Anatomy 0.000 abstract description 4
- 210000001672 ovary Anatomy 0.000 abstract description 4
- 230000009467 reduction Effects 0.000 abstract description 4
- 230000001771 impaired effect Effects 0.000 abstract description 3
- 230000028327 secretion Effects 0.000 abstract description 3
- 206010027476 Metastases Diseases 0.000 abstract description 2
- 230000012292 cell migration Effects 0.000 abstract description 2
- 230000009401 metastasis Effects 0.000 abstract description 2
- 230000003248 secreting effect Effects 0.000 abstract description 2
- 240000004371 Panax ginseng Species 0.000 description 29
- 208000015181 infectious disease Diseases 0.000 description 9
- 239000011782 vitamin Substances 0.000 description 8
- 229940088594 vitamin Drugs 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 230000037303 wrinkles Effects 0.000 description 7
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 6
- 230000036039 immunity Effects 0.000 description 6
- 238000009395 breeding Methods 0.000 description 5
- 230000001488 breeding effect Effects 0.000 description 5
- 238000009792 diffusion process Methods 0.000 description 5
- 210000003743 erythrocyte Anatomy 0.000 description 5
- 229940088597 hormone Drugs 0.000 description 5
- 239000005556 hormone Substances 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- 230000004060 metabolic process Effects 0.000 description 4
- 239000003053 toxin Substances 0.000 description 4
- 231100000765 toxin Toxicity 0.000 description 4
- 230000032683 aging Effects 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 230000002929 anti-fatigue Effects 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 230000003821 menstrual periods Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 201000010153 skin papilloma Diseases 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 210000001215 vagina Anatomy 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 108010059616 Activins Proteins 0.000 description 2
- 102000005606 Activins Human genes 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 208000000260 Warts Diseases 0.000 description 2
- 239000000488 activin Substances 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 102000015694 estrogen receptors Human genes 0.000 description 2
- 108010038795 estrogen receptors Proteins 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- 206010005949 Bone cancer Diseases 0.000 description 1
- 208000018084 Bone neoplasm Diseases 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- KQLDDLUWUFBQHP-UHFFFAOYSA-N Cordycepin Natural products C1=NC=2C(N)=NC=NC=2N1C1OCC(CO)C1O KQLDDLUWUFBQHP-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000004449 DNA Virus Infections Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 206010019375 Helicobacter infections Diseases 0.000 description 1
- 241000701806 Human papillomavirus Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 244000082490 Proboscidea louisianica Species 0.000 description 1
- 235000015926 Proboscidea louisianica ssp. fragrans Nutrition 0.000 description 1
- 235000015925 Proboscidea louisianica subsp. louisianica Nutrition 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 208000019802 Sexually transmitted disease Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 241000934136 Verruca Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 201000004196 common wart Diseases 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- OFEZSBMBBKLLBJ-BAJZRUMYSA-N cordycepin Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)C[C@H]1O OFEZSBMBBKLLBJ-BAJZRUMYSA-N 0.000 description 1
- OFEZSBMBBKLLBJ-UHFFFAOYSA-N cordycepine Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)CC1O OFEZSBMBBKLLBJ-UHFFFAOYSA-N 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 201000010251 cutis laxa Diseases 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 231100000284 endotoxic Toxicity 0.000 description 1
- 230000002346 endotoxic effect Effects 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 210000001723 extracellular space Anatomy 0.000 description 1
- 210000004996 female reproductive system Anatomy 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 description 1
- 229940099552 hyaluronan Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 239000001573 invertase Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 208000003154 papilloma Diseases 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 230000036555 skin type Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000002477 vacuolizing effect Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/18—Iodine; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Developmental Biology & Embryology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to pharmaceutical technology fields, the drug of the anti-HPV of increase human body cell activity a kind of is provided, includes reed reed grass, liquid mineral substance, cordyceps sinensis, Ganoderma Lucidum, Radix Ginseng Rubra, donkey-hide gelatin, west safflower, ginseng, organic Cranberry, Macfadyena unguis-cati (L.) A. Gentry, witch hazel, levisticum officinale root, naringin, aloe, Salvia japonica, organic Honeysuckle flower leaf, pot marigold and Hei Sang;Reed reed grass promotes estrogen secretion, increase estrogen secretory volume, improve female ovary function reduction, nutriment in liquid mineral substance is easy the activated cell activity that is absorbed by the body, tumour cell is purified, cordyceps sinensis inhibits growth and metastasis of tumours, and Radix Ginseng Rubra promotes impaired cell migration, it has solved genital wart caused by the HPV infection of high-risk-type and the low risk HPV infection of external genital organs and cervical carcinoma damage human skin has infectiousness, threatened the problem of patient and its family members' life safety.
Description
Technical field
The invention belongs to pharmaceutical technology fields, and in particular to a kind of drug for increasing the anti-HPV of human body cell activity.
Background technique
HPV viruse is the abbreviation of human papilloma virus, is that a kind of papilloma vacuolating virus A of papovaviridae belongs to,
It is a kind of sexually transmitted disease caused by spherical DNA virus infection.
The HPV crowd infection rate of skin-type is very universal, such as verruca vulgaris, toe wart and verruca plana, the HPV infection of high-risk-type
Genital wart caused by low risk HPV infection with external genital organs and cervical carcinoma damage human skin have infectiousness, threaten and suffer from
Person and its family members' life safety.
Summary of the invention
The invention reside in providing the drug of the anti-HPV of increase human body cell activity a kind of, with solve high-risk-type HPV infection and
Genital wart caused by the low risk HPV infection of external genital organs and cervical carcinoma damage human skin, threaten patient and its family members people
The problem of raw safety.
The invention is realized in this way the present invention provides the drug of the anti-HPV of increase human body cell activity a kind of, it include 15g-
30g reed reed grass, 5g-15g liquid mineral substance, 10g-20g cordyceps sinensis, 20g-30g Ganoderma Lucidum, 5g-10g Radix Ginseng Rubra, 2g-6g donkey-hide gelatin,
5g-25g west safflower, 5g-10g ginseng, the organic Cranberry of 10g-20g, 5g-10g Macfadyena unguis-cati (L.) A. Gentry, 5g-10g witch hazel, 5g-10g circle
Leaf angelica root, 5g-10g naringin, 5g-15g aloe, 5g-15g Salvia japonica, the organic Honeysuckle flower leaf of 5g-15g, 5g-15g pot marigold and
The black mulberry of 5g-15g.
It preferably, further include 15g-20g L-vitamin C, wherein the L-vitamin C, cordyceps sinensis and Ganoderma Lucidum contain
The sum of amount is no more than 70g.
Preferably, further include 5g-15g Bacillus acidi lactici, wherein the dosage of the Bacillus acidi lactici be less than Radix Ginseng Rubra, donkey-hide gelatin and
The sum of dosage of west safflower.
It preferably, further include 5g-10g hyaluronic acid, wherein the hyaluronic acid, ginseng, organic Cranberry and Macfadyena unguis-cati (L.) A. Gentry
The sum of dosage between 25g-45g.
Preferably, further include 2g-8g elastin, wherein the elastin, witch hazel and levisticum officinale root dosage
The sum of be no more than 20g.
It preferably, further include 2g-5g isoflavones, wherein the sum of the isoflavones, naringin and dosage of aloe are no more than
25g。
Preferably, in the liquid mineral substance comprising iodine, Zn-ef ficiency, selenium element, copper, molybdenum element, chromium,
Cobalt element and ferro element.
Compared with the existing methods, the beneficial effects of the present invention are: reed reed grass promotes estrogen secretion, pass through increase
Estrogen secretory volume improves female ovary function reduction, and hormone, which lacks, brings to obtain various inferior health symptom, liquid mine
Nutriment in substance is easy the activated cell activity that is absorbed by the body, and minerals and the intracorporal tumour cell generation ion of people are anti-
It answers, purifies tumour cell, and carry out deep layer toxin expelling, enhance the ability of human erythrocyte Adhesion To Tumor Cells by cordyceps sinensis, inhibit
Growth and metastasis of tumours promotes impaired cell migration by Radix Ginseng Rubra, improves skin quality, solved the HPV infection of high-risk-type
Genital wart caused by low risk HPV infection with external genital organs and cervical carcinoma damage human skin have infectiousness, threaten and suffer from
The problem of person and its family members' life safety.
Specific embodiment
The technical method in inventive embodiments will be clearly and completely described below, it is clear that described embodiment
Only invention a part of the embodiment, instead of all the embodiments.Based on the embodiment in invention, ordinary skill people
Member's every other embodiment obtained without making creative work, belongs to the range of invention protection.
Embodiment 1
The present invention provides the drug of the anti-HPV of increase human body cell activity a kind of, includes 15g-30g reed reed grass, 5g-15g liquid mine
Substance, 10g-20g cordyceps sinensis, 20g-30g Ganoderma Lucidum, 5g-10g Radix Ginseng Rubra, 2g-6g donkey-hide gelatin, 5g-25g west safflower, 5g-10g people
Ginseng, the organic Cranberry of 10g-20g, 5g-10g Macfadyena unguis-cati (L.) A. Gentry, 5g-10g witch hazel, 5g-10g levisticum officinale root, 5g-10g naringin,
5g-15g aloe, 5g-15g Salvia japonica, the organic Honeysuckle flower leaf of 5g-15g, 5g-15g pot marigold and the black mulberry of 5g-15g.
In the present embodiment, estrogen secretion is promoted by reed reed grass, improves women skin quality from the root,
Female ovary function reduction is adjusted, hormone lacks brought all kinds of inferior health symptom, passes through liquid mineral substance human activin
Cell activity, while liquid mineral substance generates ionic reaction with tumour cell in human body, purifies tumour cell and thin by tumour
The normal cell of born of the same parents' pollution, and deep layer toxin expelling is carried out to cell, it is thin to enhance red blood cell adhesion tumour by the cordycepin in cordyceps sinensis
The ability of born of the same parents, initial infection inactivate tumour cell by red blood cell, the later period are infected, by red blood cell to tumour cell
Inhibition is generated, immunity of human body itself is improved by Ganoderma Lucidum, inhibits the breeding of tumour cell, human body blood is improved by west safflower
The blood supply ability of liquid circulation, improves blood microcirculation, supplements blood, moisture and the nutrition of each cell in human body, reinforces
In human body while the activity of red blood cell, pigment is adjusted in the precipitating of skin surface, wrinkle and melanin is reduced, makes skin more
Exquisite luster is flexible.
In the present embodiment, the central nervous system of human body is adjusted by ginseng, is accelerated metabolism in human body, is passed through
Accelerate human metabolism's circulation the intracorporal toxin of people will to be discharged in human body, a variety of pathogenic bacterias are inhibited by organic Cranberry
Growth and breeding, prevention and control female reproductive system infection and inhibit Helicobacter pylori infection, maintain female reproduction
The normal pH value of system.
It further, further include 15g-20g L-vitamin C, wherein the L-vitamin C, cordyceps sinensis and Ganoderma Lucidum
The sum of content is no more than 70g.
In the present embodiment, the D-Glucose in plant can become vitamin C via invertase, be given birth to by left-handed dimension
Plain C inhibits Tyrosinase and reduction melanin, and the spot desalinated to be formed, and inhibits melanin to be formed, promotes human collagen egg
White synthesis reduces microgroove, if lacking L-vitamin C in human body be easy to cause cutis laxa aging, generate wrinkle, more aging
The content of L-vitamin C contained by skin is fewer, therefore need to supplement at any time, when skin is influenced by external environment, will form free
Free radical, free radical can destroy collagen, elastin in normal tissue, cause aging, generate microgroove and wrinkle, left-handed dimension
Raw element C can effectively neutralize free radical, improve skin lines, restore impaired skin, make skin consolidation flexible, while increasing human body
The elasticity of skin.
It further, further include 5g-15g Bacillus acidi lactici, wherein the dosage of the Bacillus acidi lactici is less than Radix Ginseng Rubra, donkey-hide gelatin
The sum of with the dosage of west safflower.
In the present embodiment, Bacillus acidi lactici prevents invasion and field planting of the pathogen to enteron aisle, inhibits pathogen, anti-sense
Dye maintains the intracorporal microecological balance of people, prevention and the generation for inhibiting tumour, enhances human body immunity of organisms, promotes digestion, closes
At amino acid and vitamin, cholesterol is reduced, inhibits endotoxic production, is delayed senescence and anti-radiation and other effects, when human body intestines
Bacillus acidi lactici quantity in road is reduced or is lost, and flora imbalance occurs, so that it may the generation for leading to certain disease, when the cream in enteron aisle
Acidfast bacilli quantity increases, and fauna is balanced, so that it may promote human body body health and treatment disease.
It further, further include 5g-10g hyaluronic acid, wherein the hyaluronic acid, ginseng, organic Cranberry and ram's horn
The sum of dosage of rattan is between 25g-45g.
In the present embodiment, hyaluronic acid is to constitute the connective tissues such as human body cell gap, vitreum, knuckle synovia
Main component, in vivo play water conservation, maintain intraor extracellular space, adjust osmotic pressure, lubrication, promote cell repair it is important
Physiological function contains a large amount of hydroxyl and carboxyl in hyaluronan molecule, forms intramolecular and intermolecular hydrogen in aqueous solution
Key, this makes it have powerful water retention, and in combination with itself 400 times or more of water, hyaluronic acid is as intercellular matrix
Main component, the directly regulation of participation intraor extracellular electrolyte exchange play the filter effect of physics and molecular information.Big point
Sub- hyaluronic acid is mobile to cell, be proliferated, differentiation and phagocytic function have inhibiting effect, and micromolecule hyaluronic acid then has promotion to make
With.
Further, further include 2g-8g elastin, wherein the elastin, witch hazel and levisticum officinale root use
The sum of amount is no more than 20g.
In the present embodiment, elastin is the protein hydrolysate of a kind of water-insoluble, high intersection degree, elastin laminin molecule
Middle nonpolar amino acid accounts for 95%, and for Glycine Levels close to the one third of total amount, proline accounts for 10%, and hydroxyproline accounts for 1%, bullet
Power albumen is antiacid, basic hydrolysis, and 100 DEG C or less are broken solvent insoluble in a variety of hydrogen bonds, and are swollen, insoluble in phenol solvent.
In addition to being broken peptide bond agent, it does not dissolve in any solvent.Elastin laminin is a kind of in the presence of water with rubber ductility and low bullet
Property modulus polymer, elastomer coexists with collagenous fibres by elastin laminin, assign human connective tissue with elasticity and
Expanding ability.
It further, further include 2g-5g isoflavones, wherein the sum of the isoflavones, naringin and dosage of aloe do not surpass
Cross 25g.
In the present embodiment, isoflavones has a dual regulation, isoflavones be used as in chemistry analogue with
Estrogenic activity is related, and display inhibits and bidirectional modulation effect of collaboration, and when human body inner estrogen is horizontal relatively low, isoflavones is accounted for
According to estrogen receptor, weak estrogen effect is played, the effect for improving estrogen level is shown, when the horizontal mistake of human body inner estrogen
Gao Shi, isoflavones occupy acceptor site, it is selective in conjunction with estrogen receptor and property mildly with brain, prostate, bladder, the heart
The affinity of the receptors such as blood vessel and bone tissue is strong, weak to the affinity of uterus, ovary, mammary gland etc., while isoflavones activity only has
The one thousandth of female hormone and ten a ten thousandths, thus avoid complementing estrogen and may induce the risk of cancer.
Further, iodine, Zn-ef ficiency, selenium element, copper, molybdenum element, chromium member are included in the liquid mineral substance
Element, cobalt element and ferro element.
In the present embodiment, the microelements such as calcium, magnesium, potassium, sodium, phosphorus, sulphur and chlorine, micro member are included in liquid mineral substance
Element content in body burden is few, but has powerful biological effect, directly the metabolic process of participation enzyme, hormone and accounting,
Its physiological function is mainly shown as assistance conveying macroelement, constituent or activator of the microelement as enzyme, in hormone
With unique effect is played in vitamin, nucleic acid metabolism etc. is influenced, by thin in the microelement human activin in liquid mineral substance
Cytoactive, while the microelement in liquid mineral substance and the intracorporal tumour cell of people generate ionic reaction, improve human body cell
Interior environment, the normal cell for purifying tumour cell and being polluted by tumour cell, and deep layer toxin expelling is carried out to cell.
In the present embodiment, the sum of dosage of L-vitamin, cordyceps sinensis and Ganoderma Lucidum is no more than 70g, the use of Ganoderma Lucidum
The dosage for measuring compare L-vitamin and cordyceps sinensis is more, and Ganoderma Lucidum has antifatigue, anti-aging, beautifying face and moistering lotion, improves human body
Immunity function, prevents tumour cell diffusive infection, the dosage of Bacillus acidi lactici be less than Radix Ginseng Rubra, donkey-hide gelatin and west safflower dosage it
It is greater than the dosage of Bacillus acidi lactici with, the sum of dosage of Radix Ginseng Rubra, donkey-hide gelatin and west safflower, reduces Bacillus acidi lactici to Radix Ginseng Rubra, donkey-hide gelatin
With the effect of west safflower, its resistance infection is improved while Bacillus acidi lactici maintains vagina self-cleaning, reduces HPV tumour
Cellular invasion breeding, the sum of hyaluronic acid, organic Cranberry, ginseng and Macfadyena unguis-cati (L.) A. Gentry dosage between 25g-45g, hyaluronic acid,
Organic Cranberry, ginseng and Macfadyena unguis-cati (L.) A. Gentry enhance human body immunity of organisms, while preventing tumour cell diffusion couple human skin from generating
It influences, 20g is no more than by the sum of elastin, witch hazel and levisticum officinale root dosage, adjusts human body microgroove, reduces wrinkle,
It is no more than 25g by the sum of isoflavones, naringin and dosage of aloe, improvement female menstrual period is unstable, and prevention improves due to bone
Cancer caused by matter is loose.
Embodiment 2
As described in above-described embodiment 1, in the present embodiment,
It further, include 15g reed reed grass, 5g liquid mineral substance, 10g cordyceps sinensis, 20g Ganoderma Lucidum, 5g Radix Ginseng Rubra, 2g donkey-hide gelatin, 5g
West safflower, 5g ginseng, the organic Cranberry of 10g, 5g Macfadyena unguis-cati (L.) A. Gentry, 5g witch hazel, 5g levisticum officinale root, 5g naringin, 5g aloe, 5g
The organic Honeysuckle flower leaf of Salvia japonica, 5g, 5g pot marigold, the black mulberry of 5g, 15g L-vitamin C, 5g Bacillus acidi lactici, 5g hyaluronic acid, 2g bullet
Power albumen and 2g isoflavones.
In the present embodiment, the sum of dosage of 15g L-vitamin, 10g cordyceps sinensis and 20g Ganoderma Lucidum is no more than 70g,
The dosage of 20g Ganoderma Lucidum compare 15g L-vitamin and 10g cordyceps sinensis dosage it is more, Ganoderma Lucidum has antifatigue, anti-ageing
Always, beautifying face and moistering lotion, raising human immunologic function, prevent tumour cell diffusive infection, and the dosage of 5g Bacillus acidi lactici is less than 5g rising star
The sum of ginseng, 2g donkey-hide gelatin and dosage of 5g west safflower are greater than by the sum of setting 5g Radix Ginseng Rubra, 2g donkey-hide gelatin and dosage of 5g west safflower
The dosage of 5g Bacillus acidi lactici reduces Bacillus acidi lactici and has an impact to Radix Ginseng Rubra, donkey-hide gelatin and west safflower, maintains vagina in Bacillus acidi lactici
Its resistance infection is improved while self-cleaning, reduces the diffusion breeding of HPV tumour cell, the organic Cranberry of 5g hyaluronic acid, 10g, 5g
Between 25g-45g, hyaluronic acid, organic Cranberry, ginseng and Macfadyena unguis-cati (L.) A. Gentry enhance human body for the sum of ginseng and 5g Macfadyena unguis-cati (L.) A. Gentry dosage
Immunity of organisms, while preventing tumour cell diffusion couple human skin from having an impact, pass through 2g elastin, 5g witch hazel and 5g
The sum of levisticum officinale root dosage is no more than 20g, adjusts human body microgroove, reduces wrinkle, passes through 2g isoflavones, 5g naringin and 5g reed
The sum of dosage of luxuriant growth is no more than 25g, and improvement female menstrual period is unstable, and prevention improves the cancer as caused by osteoporosis.
Embodiment 3
As described in above-described embodiment 1, in the present embodiment,
It further, include 30g reed reed grass, 15 liquid mineral substances, 20g cordyceps sinensis, 30g Ganoderma Lucidum, 10g Radix Ginseng Rubra, 6g donkey-hide gelatin, 25
West safflower, 10g ginseng, the organic Cranberry of 20g, 5g Macfadyena unguis-cati (L.) A. Gentry, 10g witch hazel, 5g levisticum officinale root, 5g naringin, 15g reed
Luxuriant growth, 15g Salvia japonica, the organic Honeysuckle flower leaf of 15g, 15g pot marigold, the black mulberry of 15g, 20g L-vitamin C, 15g Bacillus acidi lactici, 10g are saturating
Bright matter acid, 5g elastin and 5g isoflavones.
In the present embodiment, the sum of dosage of 20g L-vitamin, 20g cordyceps sinensis and 30g Ganoderma Lucidum is no more than 70g,
The dosage of 30g Ganoderma Lucidum compare 20g L-vitamin and 20g cordyceps sinensis dosage it is more, Ganoderma Lucidum has antifatigue, anti-ageing
Always, beautifying face and moistering lotion, raising human immunologic function prevent tumour cell diffusive infection, and it is red that the dosage of 15g Bacillus acidi lactici is less than 10g
The sum of ginseng, 6g donkey-hide gelatin and dosage of 25g west safflower pass through the sum of setting 5g Radix Ginseng Rubra, 2g donkey-hide gelatin and dosage of 5g west safflower
It greater than the dosage of 5g Bacillus acidi lactici, reduces Bacillus acidi lactici and Radix Ginseng Rubra, donkey-hide gelatin and west safflower is had an impact, maintained in Bacillus acidi lactici
Its resistance infection is improved while vagina self-cleaning, reduces the diffusion breeding of HPV tumour cell, while a large amount of uses of 25g west safflower
Maintenance adjusting is carried out to the intracorporal blood of people, the blood oxygen supply capacity to promote blood circulation improves microcirculation in blood body, supplement
Blood oxygen, moisture and the nutrition of human body cell, adjuster colour of skin element reduce human body wrinkle, 10g hyaluronic acid, 20g it is organic it is climing more
Between 25g-45g, hyaluronic acid, organic Cranberry, ginseng and Macfadyena unguis-cati (L.) A. Gentry increase for the sum of the certain kind of berries, 10g ginseng and 5g Macfadyena unguis-cati (L.) A. Gentry dosage
Strong man's body immunity of organisms, while preventing tumour cell diffusion couple human skin from having an impact, pass through 5g elastin, 10g gold
The sum of thread plum and 5g levisticum officinale root dosage are no more than 20g, adjust human body microgroove, reduce wrinkle, pass through 5g isoflavones, 5g citrus
The sum of dosage of glycosides and 15g aloe is no more than 25g, and improvement female menstrual period is unstable, and prevention improves as caused by osteoporosis
Cancer.
It is understood that a variety of to the progress of these embodiments can change in the case where not departing from the principle and spirit of invention,
Modification, replacement and variant, the range of invention are defined by the appended claims and the equivalents thereof.
Claims (7)
1. a kind of drug for increasing the anti-HPV of human body cell activity, it is characterised in that: include 15g-30g reed reed grass, 5g-15g liquid
Minerals, 10g-20g cordyceps sinensis, 20g-30g Ganoderma Lucidum, 5g-10g Radix Ginseng Rubra, 2g-6g donkey-hide gelatin, 5g-25g west safflower, 5g-10g people
Ginseng, the organic Cranberry of 10g-20g, 5g-10g Macfadyena unguis-cati (L.) A. Gentry, 5g-10g witch hazel, 5g-10g levisticum officinale root, 5g-10g naringin,
5g-15g aloe, 5g-15g Salvia japonica, the organic Honeysuckle flower leaf of 5g-15g, 5g-15g pot marigold and the black mulberry of 5g-15g.
2. a kind of drug for increasing the anti-HPV of human body cell activity according to claim 1, it is characterised in that: further include
15g-20g L-vitamin C, wherein the sum of content of the L-vitamin C, cordyceps sinensis and Ganoderma Lucidum is no more than 70g.
3. a kind of drug for increasing the anti-HPV of human body cell activity according to claim 1, it is characterised in that: further include 5g-
15g Bacillus acidi lactici, wherein the dosage of the Bacillus acidi lactici is less than the sum of Radix Ginseng Rubra, donkey-hide gelatin and dosage of west safflower.
4. a kind of drug for increasing the anti-HPV of human body cell activity according to claim 1, it is characterised in that: further include 5g-
10g hyaluronic acid, wherein the hyaluronic acid, ginseng, organic Cranberry and Macfadyena unguis-cati (L.) A. Gentry the sum of dosage between 25g-45g.
5. a kind of drug for increasing the anti-HPV of human body cell activity according to claim 1, it is characterised in that: further include 2g-
8g elastin, wherein the sum of dosage of the elastin, witch hazel and levisticum officinale root is no more than 20g.
6. a kind of drug for increasing the anti-HPV of human body cell activity according to claim 1, it is characterised in that: further include 2g-
5g isoflavones, wherein the sum of the isoflavones, naringin and dosage of aloe are no more than 25g.
7. a kind of drug for increasing the anti-HPV of human body cell activity according to claim 1, it is characterised in that: the liquid
It include iodine, Zn-ef ficiency, selenium element, copper, molybdenum element, chromium, cobalt element and ferro element in minerals.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910630800.4A CN110201150A (en) | 2019-07-12 | 2019-07-12 | A kind of drug increasing the anti-HPV of human body cell activity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910630800.4A CN110201150A (en) | 2019-07-12 | 2019-07-12 | A kind of drug increasing the anti-HPV of human body cell activity |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110201150A true CN110201150A (en) | 2019-09-06 |
Family
ID=67797319
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910630800.4A Pending CN110201150A (en) | 2019-07-12 | 2019-07-12 | A kind of drug increasing the anti-HPV of human body cell activity |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110201150A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115486538A (en) * | 2022-09-14 | 2022-12-20 | 广州通泽医疗科技有限公司 | Composition with female reproductive system protection effect and preparation method and application thereof |
Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1960743A (en) * | 2003-04-16 | 2007-05-09 | 薰衣草作物项目有限公司 | Herbal composition |
CN101032607A (en) * | 2007-03-31 | 2007-09-12 | 王成斌 | Medicine for treating pointed condyloma |
CN103041283A (en) * | 2011-10-12 | 2013-04-17 | 薛晓鸥 | Externally-used traditional Chinese medicine composition for treating cervical HPV infection and preparation method thereof |
CN103341106A (en) * | 2013-07-29 | 2013-10-09 | 北京百睿宏嘉生物科技有限公司 | Cordyceps sinensis antisepsis and anti-inflammation gel and preparation method thereof |
CN104042654A (en) * | 2013-03-12 | 2014-09-17 | 江中药业股份有限公司 | Application of composition in preparation of anti-HPV (human papillomavirus) health product or medicine or product |
CN104839650A (en) * | 2015-04-08 | 2015-08-19 | 劲膳美生物科技股份有限公司 | Medical formula food for cervical cancer |
CN107184911A (en) * | 2017-06-19 | 2017-09-22 | 太原谷歌医药科技有限公司 | One kind is used to prevent cervical carcinoma and treatment papillomavirus(HPV)Infection and the product and preparation method of colpitis |
CN108186718A (en) * | 2018-03-13 | 2018-06-22 | 余晓晴 | A kind of gynaecology's spray prevented and inhibit HPV viruse |
CN108542954A (en) * | 2018-05-22 | 2018-09-18 | 湖南千金养生坊健康品股份有限公司 | A kind of Traditional Chinese medicine gel composition of inhibitory anti-virus |
CN108853287A (en) * | 2018-08-07 | 2018-11-23 | 吉林省正肽生物科技有限公司 | Pharmaceutical composition, gel preparation and the application of a kind of anti-human papilloma virus (anti-HPV) and anti-gynaecological imflammation |
CN108976269A (en) * | 2018-01-24 | 2018-12-11 | 李立 | A method of high-purity aurantiin is quickly prepared from the fresh young fruit of shaddock |
CN109106806A (en) * | 2018-06-20 | 2019-01-01 | 广州宏韵医药科技股份有限公司 | A kind of women secret nursing washing lotion and preparation method thereof |
CN109674903A (en) * | 2019-01-29 | 2019-04-26 | 罗梦芝 | One curing hysteromyoma, uterus adenomyosis, cervical polyp, HPV therapeutic agent |
-
2019
- 2019-07-12 CN CN201910630800.4A patent/CN110201150A/en active Pending
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1960743A (en) * | 2003-04-16 | 2007-05-09 | 薰衣草作物项目有限公司 | Herbal composition |
CN101032607A (en) * | 2007-03-31 | 2007-09-12 | 王成斌 | Medicine for treating pointed condyloma |
CN103041283A (en) * | 2011-10-12 | 2013-04-17 | 薛晓鸥 | Externally-used traditional Chinese medicine composition for treating cervical HPV infection and preparation method thereof |
CN104042654A (en) * | 2013-03-12 | 2014-09-17 | 江中药业股份有限公司 | Application of composition in preparation of anti-HPV (human papillomavirus) health product or medicine or product |
CN103341106A (en) * | 2013-07-29 | 2013-10-09 | 北京百睿宏嘉生物科技有限公司 | Cordyceps sinensis antisepsis and anti-inflammation gel and preparation method thereof |
CN104839650A (en) * | 2015-04-08 | 2015-08-19 | 劲膳美生物科技股份有限公司 | Medical formula food for cervical cancer |
CN107184911A (en) * | 2017-06-19 | 2017-09-22 | 太原谷歌医药科技有限公司 | One kind is used to prevent cervical carcinoma and treatment papillomavirus(HPV)Infection and the product and preparation method of colpitis |
CN108976269A (en) * | 2018-01-24 | 2018-12-11 | 李立 | A method of high-purity aurantiin is quickly prepared from the fresh young fruit of shaddock |
CN108186718A (en) * | 2018-03-13 | 2018-06-22 | 余晓晴 | A kind of gynaecology's spray prevented and inhibit HPV viruse |
CN108542954A (en) * | 2018-05-22 | 2018-09-18 | 湖南千金养生坊健康品股份有限公司 | A kind of Traditional Chinese medicine gel composition of inhibitory anti-virus |
CN109106806A (en) * | 2018-06-20 | 2019-01-01 | 广州宏韵医药科技股份有限公司 | A kind of women secret nursing washing lotion and preparation method thereof |
CN108853287A (en) * | 2018-08-07 | 2018-11-23 | 吉林省正肽生物科技有限公司 | Pharmaceutical composition, gel preparation and the application of a kind of anti-human papilloma virus (anti-HPV) and anti-gynaecological imflammation |
CN109674903A (en) * | 2019-01-29 | 2019-04-26 | 罗梦芝 | One curing hysteromyoma, uterus adenomyosis, cervical polyp, HPV therapeutic agent |
Non-Patent Citations (5)
Title |
---|
孔令义主编: "《天然药物化学》", 31 August 2015 * |
张正付等: "鼠尾草属植物化学成分及活性研究新进展" * |
张雷红等主编: "《天然药物化学 第3版》", 31 January 2017 * |
王磊: "黑桑化学成分及生物活性研究" * |
阎冰冰等: "乳酸杆菌对阻断高危型HPV持续性感染作用的前瞻性研究" * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115486538A (en) * | 2022-09-14 | 2022-12-20 | 广州通泽医疗科技有限公司 | Composition with female reproductive system protection effect and preparation method and application thereof |
CN115486538B (en) * | 2022-09-14 | 2023-09-15 | 广州通泽医疗科技有限公司 | Composition with female reproductive system protection effect, and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107823095A (en) | A kind of active peptide facial mask | |
CN111574618A (en) | Preparation method of whitening compound protein peptidase hydrolysate, whitening compound protein peptide beverage and preparation method thereof | |
CN102085172B (en) | Skin care cosmetic taking American wild yam extract as main component and preparation method thereof | |
CN208279353U (en) | A kind of mist small molecule hydrogen-rich water preparation apparatus | |
CN105639560A (en) | Biological-enzymolysis-method sporoderm-broken lucid ganoderma spore powder honey for calming nerves and aiding sleep and production process thereof | |
WO2018000665A1 (en) | Essential liquid for making breasts plump and firm and preventing breast diseases | |
CN109998937A (en) | Serial cosmetics and preparation method thereof containing glycosylglycerol (α GG) | |
CN110201150A (en) | A kind of drug increasing the anti-HPV of human body cell activity | |
CN102972872A (en) | Breast enlarging and beautifying anti-sag bra | |
CN105902477B (en) | The comprehensive biological agent and preparation method thereof for improving eye vigor | |
CN110151975A (en) | A kind of anti-radiation blue light improves the clear and rich liquid and preparation method thereof of eyesight | |
CN109172491A (en) | A kind of creme and preparation method thereof with anti-aging and activating microcirculation and removing stasis medicinal function | |
CN106333977A (en) | Natural drug composition for treatment of osteoporotic fracture and/or osteoarthritis and application thereof | |
CN108056964A (en) | A kind of U.S.'s chest essential oil composition | |
CN108030012A (en) | Health food with body-beautifying and face-nourishing effects | |
CN107823079A (en) | A kind of sea cucumber EGF composition skin-care cosmetics and preparation method thereof | |
CN106620402A (en) | Traditional Chinese medicine composition taken after operation of liver cancer and preparation method thereof | |
CN116212007B (en) | Bone-knitting and tendon-softening traditional Chinese medicine composition for treating metaphase fracture and preparation method thereof | |
CN109701006A (en) | It is a kind of to improve women microcirculation, the composition in the warm palace of menstruation regulating and preparation method thereof | |
CN108355005A (en) | A kind of Chinese patent drug for treating the protrasion of the lumbar intervertebral disci | |
CN104587456A (en) | Production process for health product capable of increasing bone mineral density | |
CN110200957A (en) | Flufenamic acid prevents and treats the application in medicine for treating osteoporosis in preparation | |
CN108295016A (en) | A kind of chest enlarge gel | |
CN107375333A (en) | Treat intacellin biogel preparation of premature ovarian failure and preparation method thereof | |
CN102389140A (en) | Method for solving compatibility problem of grape seed extract and collagen aqueous solution |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190906 |